Veraxa Biotech Holding AG (VRXA) Assets (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) posted Assets of $101.1 million for Q4 2025, up 4.5% on a QoQ basis from $96.8 million in Q4 2024, and up 4.5% YoY from $96.8 million in Q4 2024.

Veraxa Biotech Holding AG (VRXA) Assets (2024 - 2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has reported Assets for 2 consecutive years, with $101.1 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Assets rose 4.5% year-over-year to $101.1 million; the trailing twelve-month figure through Dec 2025 stood at $101.1 million (up 4.5% YoY), and the FY2025 full-year result was $101.1 million, up 4.5% from the prior year.
  • Assets rose to $101.1 million in Q4 2025 per VRXA's latest filing, from $96.8 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $101.1 million in Q4 2025 to a low of $96.8 million in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 101.12 Mn
Dec 31, 2024 96.76 Mn